Nektar Therapeutics Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 273.0 | 217.7 | 126.3 |
| Cost of Goods Sold | 147.5 | 118.1 | 36.0 |
| Gross Profit | 125.5 | 99.6 | 90.3 |
| Gross Profit Margin | 46.0% | 45.8% | 71.5% |
| SG&A Expense | 133.5 | 226.2 | 246.7 |
| Depreciation & Amortization | 28.1 | 32.6 | 26.2 |
| Operating Income | (36.2) | (159.2) | (182.6) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 23.3 | 25.5 | 11.5 |
| Nonoperating Expenses | 18.6 | 20.3 | 14.1 |
| Income Before Taxes | (31.5) | (153.9) | (185.3) |
| Income Taxes | 1.3 | 0.8 | (0.1) |
| Net Income After Taxes | (32.8) | (154.8) | (185.1) |
| Continuing Operations | (32.8) | (154.8) | (185.1) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (32.8) | (154.8) | (185.1) |
| Total Net Income | (32.8) | (154.8) | (185.1) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.36) | (1.72) | (2.15) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
